Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pancreatic phenotype in infants with cystic fibrosis identified by mutation screening.

Archives of disease in childhood - 1 Oct 2007

Cipolli Marco, Castellani Carlo, Wilcken Bridget, Massie John, McKay Karen, Gruca Margie, Tamanini Anna, Assael Maurice Baroukh, Gaskin Kevin

Abstract excerpt

OBJECTIVE: To determine the pancreatic phenotype of infants with cystic fibrosis (CF) diagnosed in the first week of life by a combined immunoreactive trypsin/mutation screening program. DESIGN: A prospective evaluation of pancreatic function in infants with CF at the time of neonatal diagnosis and up to the age of 12. SETTING: Two different centres (Verona, Italy and Westmead, Australia) to enable comparison of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child, Preschool
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exocrine Pancreatic Insufficiency

Share to Infant

Share to Infant, Newborn

Share to Neonatal Screening

Share to Nutritional Status

Share to Pregnancy

Source

Open in PubMed Open full text

Identifiers

PMID: 17449517
DOI: 10.1136/adc.2006.107581
PMCID: PMC2083233

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pancreatic phenotype in infants with cystic fibrosis identified by mutation screening.PMID 17449517Read ↗

Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels.Semantic proximity Read ↗

Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study.Semantic proximity Read ↗

Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations.Semantic proximity Read ↗

Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening.Semantic proximity Read ↗

The pancreas in cystic fibrosis.Semantic proximity Read ↗

[Evaluation of 47,213 infants in neonatal screening for cystic fibrosis, using pancreatitis-associated protein and immunoreactive trypsinogen assays].Semantic proximity Read ↗

Clinical status and somatic development of patients with or without meconium ileus diagnosed through neonatal screening for cystic fibrosis.Semantic proximity Read ↗

Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas.Semantic proximity Read ↗

Combining Immunoreactive Trypsinogen and Pancreatitis-Associated Protein Assays, a Method of Newborn Screening for Cystic Fibrosis that Avoids DNA AnalysisSemantic proximity Read ↗

Transitory pancreatic insufficiency in cystic fibrosis children.Semantic proximity Read ↗

Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing.Semantic proximity Read ↗

Benefits of reviewing pancreatic function in children with cystic fibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.